Industry News
Ethnic disparities in cancer and genetic mutations linked
Sep 12, 2014
One of the goals of genome sequencing is to identify genetic mutations associated with increased susceptibility to disease. Read More
Ovarian cancer metastasis promoted by mesothelial cells
Sep 12, 2014
Less than half of the women diagnosed with ovarian cancer will survive beyond 5 years. Read More
Why damaged DNA contributes to cancer and other age-related illnesses
Sep 12, 2014
As we and other vertebrates age, our DNA accumulates mutations and becomes rearranged, which may result in a variety of age-related illnesses, including cancers. Read More
New mechanism that inhibits the activity of proteasomes paves the way for a new generation of chemotherapies
Sep 12, 2014
A new mechanism to inhibit proteasomes, protein complexes that are a target for cancer therapy, is the topic of an article published in the journal Chemistry & Biology. Read More
Why some sickle cell patients do not adhere to available treatment
Sep 12, 2014
Experiencing discrimination because of their race or health condition can influence just how much trust people put into the health profession. Read More
Ovarian cancer metastasis promoted by mesothelial cells
Sep 12, 2014
Less than half of the women diagnosed with ovarian cancer will survive beyond 5 years. Read More
Patients with high-risk endometrial cancer benefit from radiation therapy with concurrent chemotherapy after surgery
Sep 12, 2014
Radiation therapy with concurrent paclitaxel chemotherapy following surgery is an effective treatment for patients with high-risk endometrial cancer, according to a study published in the... Read More
Ethnic disparities in cancer and genetic mutations linked
Sep 12, 2014
One of the goals of genome sequencing is to identify genetic mutations associated with increased susceptibility to disease. Read More
Early diagnosis and detection rates of skin cancer boosted by pioneering digital application
Sep 11, 2014
The early diagnosis and detection rates of skin cancer has been boosted by a pioneering digital application developed at the University of Edinburgh which trains the medical profession to... Read More
Olaparib tablet safe in pretreated ovarian cancer patients
Sep 11, 2014
An oral tablet form of a PARP inhibitor, olaparib, given in combination with chemotherapy, was safe in heavily pretreated ovarian cancer patients, and patients with BRCA mutations may have a better... Read More
Previous Page Next Page